Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_assertion description "[It was also revealed that FOXA1 siRNA treatment of esophageal cancer cells reduced the mRNA level of both KRT7 and a stabilizer of epithelial-mesenchymal transition (EMT) regulator LOXL2, and that both FOXA1 and LOXL2 siRNAs reduced invasion and migration of ESCC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_assertion evidence source_evidence_literature NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_assertion SIO_000772 20043065 NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_assertion wasDerivedFrom befree-2016 NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_assertion wasGeneratedBy ECO_0000203 NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.
- befree-2016 importedOn "2016-02-19" NP784395.RAqQxNGqTQL4VDYtlHtcPmTvQZblhdMRc1i8uVfgrxagU130_provenance.